Inetetamab-Based Regimens for Patients with HER2-Positive Metastatic Breast Cancer: A Real-World Retrospective Study. Chen L, Huang J, Chen X, Lan X, et al. Breast Cancer (Dove Med Press) 2025;17:1427-1437.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen L, Huang J, Chen X, Lan X, et al. Inetetamab-Based Regimens for Patients with HER2-Positive Metastatic Breast Cancer: A Real-World Retrospective Study. Breast Cancer (Dove Med Press) 2025;17:1427-1437.
PMID: 41488682